Manhattan Vision Associates/institute of Vision Research
New York, 10022, United States
NCT Number: NCT04415684
Acucela Inc. intends to develop a medical device to significantly halt or reverse myopic progression, which is a significant public health concern across the world, especially in Asian demographics. Acucela is working towards a spectacle-like device (eSPECs), which will have a clear zone for unimpeded central visual tasks and a periphery that provides defocus in order to alter retinal physiology leading to myopia regulation. This study will establish the changes seen during a proof-of-concept that projected defocus in the periphery utilizing a wearable device will stimulate physiological changes similar to those in the literature.
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Not applicable
New York, 10022, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For the right/test eye, a defocused image is projected onto the peripheral retina while the subject views a distant, in-focus image
For the left/control eye, no image is projected onto the peripheral retina. The subject views a distant, in-focus image.
Time frame: 1 hour
Change in AL from baseline in the test eye vs. control eye
Time frame: 1 hour
Change in CT from baseline in the test eye vs. control eye
Kubota Vision Inc.
Industry
Effects of Projected Peripheral Defocus on Ocular Biometrics Using a Wearable Device
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT06700460
Eye Diseases, Myopia
Omaha, Nebraska, United States
View Trial DetailsNCT03334253
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial DetailsNCT00320593
Eye Diseases, Myopia
Birmingham, Alabama, United States
View Trial Details